These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28301413)

  • 1. OPHTHALMIC FINDINGS IN LATE STAGE SJOGREN-LARSSON SYNDROME.
    Nanda T; Kovach JL
    Retin Cases Brief Rep; 2019 Summer; 13(3):251-254. PubMed ID: 28301413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-Stage Sjögren-Larsson Syndrome Maculopathy Imaged With OCT Angiography.
    Kovach JL
    Ophthalmic Surg Lasers Imaging Retina; 2018 Sep; 49(9):e78-e82. PubMed ID: 30222823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal Morphology in Sjögren-Larsson Syndrome on OCT: From Metabolic Crystalline Maculopathy to Early-Onset Macular Degeneration.
    Staps P; Cruysberg JRM; Roeleveld N; Willemsen MAAP; Theelen T
    Ophthalmol Retina; 2019 Jun; 3(6):500-509. PubMed ID: 31174672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Macular crystalline dystrophy in Sjögren-Larsson syndrome: case report].
    Isaac DL; Queiroz GH; Feres CC; Avila M
    Arq Bras Oftalmol; 2009; 72(2):239-42. PubMed ID: 19466337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical changes in the juvenile crystalline macular dystrophy in Sjögren-Larsson syndrome detected by optical coherence tomography.
    Fuijkschot J; Cruysberg JR; Willemsen MA; Keunen JE; Theelen T
    Ophthalmology; 2008 May; 115(5):870-5. PubMed ID: 17826835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macular fibrosis complicating macular pigment deficient maculopathy in Sjögren-Larsson syndrome.
    Theelen T; Cruysberg JR; Willemsen MA
    Acta Ophthalmol; 2016 Nov; 94(7):e663-e664. PubMed ID: 27061911
    [No Abstract]   [Full Text] [Related]  

  • 7. Optical coherence tomography aspect of crystalline macular dystrophy in Sjögren-Larsson syndrome.
    Bhallil S; Chraibi F; Andalloussi IB; Tahri H
    Int Ophthalmol; 2012 Oct; 32(5):495-8. PubMed ID: 22932746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fundus autofluorescence changes in two cases of Sjögren-Larsson syndrome.
    Mirshahi A; Piri N
    Int Ophthalmol; 2009 Dec; 29(6):541-5. PubMed ID: 18830564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sjögren-Larsson syndrome: optical coherence tomography and a novel mutation.
    Burgueño-Montañés C; García-Fernández M; Colunga-Cueva M; García-López A
    Arch Soc Esp Oftalmol; 2014 Dec; 89(12):504-7. PubMed ID: 24377952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with Sjögren-Larsson syndrome lack macular pigment.
    van der Veen RL; Fuijkschot J; Willemsen MA; Cruysberg JR; Berendschot TT; Theelen T
    Ophthalmology; 2010 May; 117(5):966-71. PubMed ID: 20163870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal imaging of the macula in hereditary and acquired lack of macular pigment.
    Theelen T; Berendschot TT; Klevering BJ; Fuijkschot J; Hoyng CB; Willemsen MA
    Acta Ophthalmol; 2014 Mar; 92(2):138-42. PubMed ID: 23387297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmentation of Retinal Layers in Sjögren-Larsson Syndrome.
    Jack LS; Benson C; Sadiq MA; Rizzo WB; Margalit E
    Ophthalmology; 2015 Aug; 122(8):1730-2. PubMed ID: 25784589
    [No Abstract]   [Full Text] [Related]  

  • 13. Juvenile macular dystrophy associated with deficient activity of fatty aldehyde dehydrogenase in Sjögren-Larsson syndrome.
    Willemsen MA; Cruysberg JR; Rotteveel JJ; Aandekerk AL; Van Domburg PH; Deutman AF
    Am J Ophthalmol; 2000 Dec; 130(6):782-9. PubMed ID: 11124298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathophysiology of macular diseases--morphology and function].
    Iida T
    Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):238-74; discussion 275. PubMed ID: 21476310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optical coherence tomography in Sjögren-Larsson Syndrome diagnosis].
    Loukil I; Naija O; Hachicha F
    Bull Soc Belge Ophtalmol; 2012; (320):11-5. PubMed ID: 22978179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipofuscin and melanin content of the retinal pigment epithelium in a case of Sjögren-Larsson syndrome.
    Nilsson SE; Jagell S
    Br J Ophthalmol; 1987 Mar; 71(3):224-6. PubMed ID: 3828281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal imaging of torpedo maculopathy in a Chinese woman: a case report.
    Ding Y; Yao B; Ye H; Yu Y
    BMC Ophthalmol; 2019 Jul; 19(1):154. PubMed ID: 31324167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular crystalline inclusions in Sjögren-Larsson syndrome are dynamic structures that undergo remodeling.
    Al-Holou SN; Siefker E; Fouzdar-Jain S; Suh DW; Rizzo WB
    Ophthalmic Genet; 2020 Aug; 41(4):381-385. PubMed ID: 32506993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sjögren-larsson syndrome and crystalline maculopathy associated with a novel mutation.
    Jean-François E; Low JY; Gonzales CR; Sarraf D
    Arch Ophthalmol; 2007 Nov; 125(11):1582-3. PubMed ID: 17998529
    [No Abstract]   [Full Text] [Related]  

  • 20. Spectral-domain optical coherence tomography and fundus autofluorescence evaluation of torpedo maculopathy.
    Thomas AS; Flaxel CJ; Pennesi ME
    J Pediatr Ophthalmol Strabismus; 2015 Mar; 52 Online():e8-10. PubMed ID: 25751084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.